Targeting TGFβ Signal Transduction for Cancer Therapy
노바스템
2024-04-18
조회수 211
The paper explores the complex role of Transforming Growth Factor Beta (TGFβ) in cancer development and therapy. TGFβ, a multifunctional cytokine, plays divergent roles in cancer progression: it acts as a tumor suppressor in early stages and a tumor promoter in advanced stages by enhancing cancer cell invasion, metastasis, and immune suppression. The review details TGFβ’s impact on the tumor microenvironment (TME), influencing everything from cell proliferation and apoptosis to the epithelial-mesenchymal transition (EMT) and immune modulation. The therapeutic potential of targeting TGFβ is significant due to its pivotal role in cancer cell functions and the TME, but challenges remain due to its pleiotropic effects and essential roles in normal cell function.
The insights into TGFβ’s role in cancer provide a useful parallel for stem cell therapies like those developed by Novastem. Understanding how TGFβ influences the TME and cancer progression can guide the development of stem cell therapies aimed at modulating similar pathways for regenerative medicine, potentially enhancing the efficacy of treatments for conditions characterized by abnormal cell growth or immune responses.
Dual Role of TGFβ: As both a suppressor and promoter of tumors depending on the cancer stage, TGFβ’s complex role underlines the need for targeted therapeutic approaches that consider its impact on the TME.
Therapeutic Targeting Challenges: While TGFβ presents a valuable target for cancer therapy, its critical role in normal cellular processes poses risks of adverse effects, necessitating precise therapeutic strategies.
Future Directions: Combining TGFβ targeting therapies with other treatments like chemotherapy or immunotherapy could enhance efficacy and overcome resistance, a strategy that may also be relevant for integrating stem cell therapies in complex therapeutic regimens.
The paper explores the complex role of Transforming Growth Factor Beta (TGFβ) in cancer development and therapy. TGFβ, a multifunctional cytokine, plays divergent roles in cancer progression: it acts as a tumor suppressor in early stages and a tumor promoter in advanced stages by enhancing cancer cell invasion, metastasis, and immune suppression. The review details TGFβ’s impact on the tumor microenvironment (TME), influencing everything from cell proliferation and apoptosis to the epithelial-mesenchymal transition (EMT) and immune modulation. The therapeutic potential of targeting TGFβ is significant due to its pivotal role in cancer cell functions and the TME, but challenges remain due to its pleiotropic effects and essential roles in normal cell function.
The insights into TGFβ’s role in cancer provide a useful parallel for stem cell therapies like those developed by Novastem. Understanding how TGFβ influences the TME and cancer progression can guide the development of stem cell therapies aimed at modulating similar pathways for regenerative medicine, potentially enhancing the efficacy of treatments for conditions characterized by abnormal cell growth or immune responses.
#TGFβ #CancerTherapy #StemCellTherapy #Novastem #TumorMicroenvironment #EMT #ImmuneSuppression